Japer Therapeutics, Inc. Warrants (JSPRW) Stock Price
JSPRWStock
$0.01
Market Cap—
P/E—
PEG Ratio—
Div yield—
Beta3.20
JSPRW Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-104.81%
Price vs S&P 500 (4W)-33.08%
VGM Score8.16
Industry Peers — Biological Products(183)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
JSPRWJaper Therapeutics, Inc. Warrants | — | — | F | $0.01 |
| AMGNAmgen Inc | C | C | B | $432.42 |
| GILDGilead Sciences Inc | C | B | B | $145.68 |
| ARGXargenx SE American Depositary Shares | D | A | B | $1023.21 |
| MRNAModerna, Inc. Common Stock | D | C | A | $137.99 |
| RVMDRevolution Medicines, Inc. Common Stock | F | — | A | $207.88 |
| BIIBBiogen Inc. Common Stock | C | D | B | $218.50 |
| BNTXBioNTech SE American Depositary Share | C | C | C | $102.08 |
| NBIXNeurocrine Biosciences Inc | C | B | C | $154.06 |
| EXELExelixis Inc | C | B | B | $54.45 |
| HALOHalozyme Therapeutics, Inc. | C | B | B | $105.35 |
About Japer Therapeutics, Inc. Warrants
Jasper Therapeutics is a clinical-stage biotech company developing safer conditioning agents and advanced stem cell engineering technologies to expand the use of hematopoietic stem cell transplantation and ex vivo gene therapy. The company's platform aims to enable broader patient access to stem cell-based treatments by improving efficacy and safety outcomes.